George H A Clowes Jr Professor of Surgery
Harvard Medical School
Chief, Division of Vascular and Endovascular Surgery
Beth Israel Deaconess Medical Center
Boston, Massachusetts
SESSION 6: MORE ABOUT TBADS, AAAS AND EVAR, STANDARD AND COMPLEX: UPDATES ON PHYSICIAN MODIFIED ENDOGRAFTS (PMEGS) AND GUIDELINES
DEBATE: Population Screening With Ultrasound For Early Detection Of AAA Is Recommended For Women Age >65 Years, With A History Of Smoking Or A Family History Of AAA, And For Women Age >75 Years, With A History Of Smoking If They Are Otherwise In Good Health
3:34 PM - 3:39 PM
Presenter
SESSION 46: MORE SHORT HOT NEW TOPICS RELATED TO AORTC DISEASE AND ITS TREATMENT
10 Years Of PMEGs For Complex AAAs: How Do The Results Vary With And Without An IDE, The Extent Of The AAA And With And Without A Prior EVAR
5:18 PM - 5:23 PM
Presenter
SESSION 52: MORE NEW DEVELOPMENTS IN TECHNIQUES OF ENDO TREATMENT OF RUPTURED AAAS, COMPLEX AAAS AND TAAAS; WHAT IS AND SHOULD BE HAPPENING WITH AAA SCREENING
Update On Current Screening For AAAs In The US: Most Ruptured AAAs Occur In Patients Not Being Screened: How Should US PSTF Recommendations Be Changed And How Should Screening Groups Be Expanded
3:00 PM - 3:05 PM
Session Moderator
SESSION 80: NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS: UPDATE ON MESH COVERED STENTS AND TCAR (TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION)
Presenter
SESSION 80: NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS: UPDATE ON MESH COVERED STENTS AND TCAR (TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION)
Update On Comparative Performance And Risks Of TCAR, Transfemoral CAS (TFCAS) And CEA With > 50K TCAR, 25K TFCAS, And 100K CEA: This Population Based Study Shows That CEA Is Better Than TCAR Which Is Better Than TFCAS
8:42 AM - 8:47 AM
Presenter
SESSION 80: NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS: UPDATE ON MESH COVERED STENTS AND TCAR (TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION)
Favorable 30-Day Results Of TCAR In Good Risk Symptomatic And Asymptomatic Patients: Late Breaking Trial Results From ROADSTER 3 Shows That The Stroke, Death And MI Rates Are Lower Than In High Risk Patients
9:06 AM - 9:11 AM
Presenter
SESSION 89: PROGRESS IN VASCULAR IMAGING AND GUIDANCE FOR ENDOVASCULAR TREATMENTS WITH LESS RADIATION EXPOSURE OR CONTRAST TOXICITY
With F/B/EVAR For Complex AAAs, FORS Lumiguide Fiberoptic Guidance (Philips) Reduces Radiation Exposure Compared To Standard Imaging
9:46 AM - 9:51 AM
Moderator
SESSION 16: Carotid Diseases – Part II
THE SVS/ESVS/NICE/ACC/AHA DEBATES ON GUIDELINES FOR THE MANAGEMENT OF ABDOMINAL AORTIC ANEURYSMS
FRIDAY, NOVEMBER 22, 2024
AMERICAS HALL 1, 3RD FLOOR
PRESENTER
10:45 AM - 10:50 AM
Debate: SVS: Population Screening With Ultrasound For Early Detection Of Abdominal Aortic Aneurysms Is Recommended For Women Age >65 Years, With A History Of Smoking Or A Family History Of AAA, And For Women Age >75 Years, With A History Of Smoking, If They Are Otherwise In Good Health
FRIDAY, NOVEMBER 22, 2024
AMERICAS HALL 1, 3RD FLOOR
PRESENTER
10:45 AM - 10:50 AM
Debate: SVS: Population Screening With Ultrasound For Early Detection Of Abdominal Aortic Aneurysms Is Recommended For Women Age >65 Years, With A History Of Smoking Or A Family History Of AAA, And For Women Age >75 Years, With A History Of Smoking, If They Are Otherwise In Good Health